2024. Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s431. DOI:https://doi.org/10.25251/skin.8.supp.431.